These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38718927)

  • 1. Application of machine learning approaches for predicting hemophilia A severity.
    Rawal A; Kidchob C; Ou J; Sauna ZE
    J Thromb Haemost; 2024 Jul; 22(7):1909-1918. PubMed ID: 38718927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype-genotype correlations in hemophilia A carriers are consistent with the binary role of the phase between F8 and X-chromosome inactivation.
    Radic CP; Rossetti LC; Abelleyro MM; Tetzlaff T; Candela M; Neme D; Sciuccati G; Bonduel M; Medina-Acosta E; Larripa IB; de Tezanos Pinto M; De Brasi CD
    J Thromb Haemost; 2015 Apr; 13(4):530-9. PubMed ID: 25611311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.
    Boylan B; Rice AS; De Staercke C; Eyster ME; Yaish HM; Knoll CM; Bean CJ; Miller CH;
    J Thromb Haemost; 2015 Jun; 13(6):1036-42. PubMed ID: 25780857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene.
    Chao BN; Baldwin WH; Healey JF; Parker ET; Shafer-Weaver K; Cox C; Jiang P; Kanellopoulou C; Lollar P; Meeks SL; Lenardo MJ
    J Thromb Haemost; 2016 Feb; 14(2):346-55. PubMed ID: 26588198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hemophilia A caused by an unbalanced chromosomal rearrangement identified using nanopore sequencing.
    Chatron N; Schluth-Bolard C; Frétigny M; Labalme A; Vilchez G; Castet SM; Négrier C; Sanlaville D; Vinciguerra C; Jourdy Y
    J Thromb Haemost; 2019 Jul; 17(7):1097-1103. PubMed ID: 31021037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of an in vitro cellular expression model for haemophilia A carrier diagnosis: illustration with five novel mutations in the F8 gene in women with isolated factor VIII:C deficiency.
    Roualdes O; Nougier C; Fretigny M; Talagrand E; Durand B; Negrier C; Vinciguerra C
    Haemophilia; 2015 May; 21(3):e202-e209. PubMed ID: 25708597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole F8 gene sequencing identified pathogenic structural variants in the remaining unsolved patients with severe hemophilia A.
    Jourdy Y; Chatron N; Frétigny M; Zawadzki C; Lienhart A; Stieltjes N; Rohrlich PS; Thauvin-Robinet C; Volot F; Hamida YF; Hariti G; Leuci A; Dargaud Y; Sanlaville D; Vinciguerra C
    J Thromb Haemost; 2024 Jun; 22(6):1616-1626. PubMed ID: 38484912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of seven novel mutations in the factor VIII gene in 18 unrelated Chinese patients with hemophilia A.
    Hua BL; Yan ZY; Liang Y; Yan M; Fan LK; Li KX; Xiao B; Liu JZ; Zhao YQ
    Chin Med J (Engl); 2010 Feb; 123(3):305-10. PubMed ID: 20193250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First report of molecular diagnosis of Tunisian hemophiliacs A: identification of 8 novel causative mutations.
    Elmahmoudi H; Khodjet-el-khil H; Wigren E; Jlizi A; Zahra K; Pellechia D; Vinciguerra C; Meddeb B; Elggaaied AB; Gouider E
    Diagn Pathol; 2012 Aug; 7():93. PubMed ID: 22883072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes.
    Bastida JM; González-Porras JR; Jiménez C; Benito R; Ordoñez GR; Álvarez-Román MT; Fontecha ME; Janusz K; Castillo D; Fisac RM; García-Frade LJ; Aguilar C; Martínez MP; Bermejo N; Herrero S; Balanzategui A; Martin-Antorán JM; Ramos R; Cebeiro MJ; Pardal E; Aguilera C; Pérez-Gutierrez B; Prieto M; Riesco S; Mendoza MC; Benito A; Hortal Benito-Sendin A; Jiménez-Yuste V; Hernández-Rivas JM; García-Sanz R; González-Díaz M; Sarasquete ME
    Thromb Haemost; 2017 Jan; 117(1):66-74. PubMed ID: 27734074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preimplantation genetic diagnosis for hemophilia A using indirect linkage analysis and direct genotyping approaches.
    Laurie AD; Hill AM; Harraway JR; Fellowes AP; Phillipson GT; Benny PS; Smith MP; George PM
    J Thromb Haemost; 2010 Apr; 8(4):783-9. PubMed ID: 20102489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII inhibitor development in Egyptian hemophilia patients: does intron 22 inversion mutation play a role?
    Sherief LM; Gaber OA; Youssef HM; Sherbiny HS; Mokhtar WA; Ali AAA; Kamal NM; Abdel Maksoud YH
    Ital J Pediatr; 2020 Sep; 46(1):129. PubMed ID: 32928254
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Atik T; Işık E; Onay H; Akgün B; Shamsali M; Kavaklı K; Evim M; Tüysüz G; Özbek NY; Şahin F; Salcıoğlu Z; Albayrak C; Oymak Y; Ünal E; Belen FB; Yılmaz Keskin E; Balkan C; Baytan B; Küpesiz A; Culha V; Tahtakesen Güçer TN; Güneş AM; Özkınay F
    Turk J Haematol; 2020 Aug; 37(3):145-153. PubMed ID: 32026663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of GPIbα on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunity.
    Chen J; Schroeder JA; Luo X; Montgomery RR; Shi Q
    J Thromb Haemost; 2019 Mar; 17(3):449-459. PubMed ID: 30609275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible mechanism for Inv22-related F8 large deletions in severe hemophilia A patients with high responding factor VIII inhibitors.
    Fujita J; Miyawaki Y; Suzuki A; Maki A; Okuyama E; Murata M; Takagi A; Murate T; Suzuki N; Matsushita T; Saito H; Kojima T
    J Thromb Haemost; 2012 Oct; 10(10):2099-107. PubMed ID: 22906111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of deep intronic variants in 15 haemophilia A patients by next generation sequencing of the whole factor VIII gene.
    Bach JE; Wolf B; Oldenburg J; Müller CR; Rost S
    Thromb Haemost; 2015 Oct; 114(4):757-67. PubMed ID: 25948085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep intronic variant c.5999-277G>A of F8 gene may be a hot spot mutation for mild hemophilia A patients without mutation in exonic DNA.
    Chang CY; Perng CL; Cheng SN; Hu SH; Wu TY; Lin SY; Chen YC
    Eur J Haematol; 2019 Jul; 103(1):47-55. PubMed ID: 31063249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in baseline factor VIII concentration in a retrospective cohort of mild/moderate hemophilia A patients carrying identical F8 mutations.
    Loomans JI; van Velzen AS; Eckhardt CL; Peters M; Mäkipernaa A; Holmstrom M; Brons PP; Dors N; Haya S; Voorberg J; van der Bom JG; Fijnvandraat K
    J Thromb Haemost; 2017 Feb; 15(2):246-254. PubMed ID: 27943580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement.
    Spena S; Garagiola I; Cannavò A; Mortarino M; Mannucci PM; Rosendaal FR; Peyvandi F;
    J Thromb Haemost; 2018 Apr; 16(4):778-790. PubMed ID: 29399993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FVIII Immunogenicity-Bioinformatic Approaches to Evaluate Inhibitor Risk in Non-severe Hemophilia A.
    Hart DP
    Front Immunol; 2020; 11():1498. PubMed ID: 32849511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.